Orthopedic Implants in Tennessee

Brace Align manufactures high-quality medical braces designed for healthcare providers and patients. The company specializes in universal-sizing orthotic solutions with moldable components that enable customization to each patient's unique anatomical requirements and recovery stage. Products span foot and ankle, back, knee, and wrist/thumb categories, engineered from lightweight, durable, breathable materials for all-day wear and enhanced treatment adherence. The universal sizing approach reduces inventory burden for healthcare facilities while maintaining clinical effectiveness across initial injury management, dynamic healing phases, and long-term support applications. Brace Align emphasizes competitive pricing, superior customer service, and evidence-based design focused on optimal patient outcomes and provider economics.

American Surgical Specialties Company is a surgical instrument and specialty medical equipment distributor serving healthcare facilities nationwide with over two decades of industry experience. The company supplies a comprehensive catalog of surgical instruments including specialty and general surgical instruments, orthopedic instruments and extraction equipment, surgical overhead light drapes, and positioning accessories. Product lines include video laryngoscopes with sheaths, shielding accessories, orthopedic foam positioning products for patient support during procedures, CO2 laser systems and CO2 fibers for surgical applications, and sterilization containers for operating room and sterile processing departments. The company also distributes PPE disposables and infection control consumables. ASSC operates as both a direct supplier to medical facilities and through distribution partnerships. The company emphasizes quality products, competitive pricing, and cross-referencing capabilities. Services include product catalog access and distribution support to hospitals, surgical centers, and other healthcare organizations. No specific FDA, ISO, or regulatory certifications are mentioned on the website.

Odyssey Medical Technologies LLC is a contract manufacturer specializing in precision medical device manufacturing for orthopedic, spine, and trauma applications. Based in Bartlett, Tennessee, the company operates world-class manufacturing facilities with advanced quality control systems designed to meet tight tolerances and exceed customer specifications. The company holds FDA registration for the manufacture of orthopedic implants and instruments, coupled with ISO 13485:2016 certification, validating their ability to deliver precision components for OEM medical device manufacturers. Odyssey's service offerings encompass design validation, precision machining, assembly, and quality assurance across the orthopedic, spine, and trauma sectors. The company was recognized as one of MedTech Outlook's "Top 10 Contract Manufacturers" in 2020. Their manufacturing capabilities include sophisticated quality control systems and unparalleled workflow processes to ensure all specifications are met consistently. The company serves as a B2B manufacturing partner for orthopedic device manufacturers requiring precision component production and assembly services.

CrossRoads Extremity Systems LLC manufactures minimally invasive surgical systems for bunion correction procedures. The company's primary product line includes the miniBunion® 3D system, a 3D minimally invasive bunion correction procedure utilizing a small micro-implant to stabilize toe alignment through a 1.5-inch incision. The company also offers the dynaBunion® 4D Bunion System for more severe bunion cases. These procedures are designed to provide faster patient recovery compared to traditional open bunion surgery (Chevron or Lapidus procedures), with many patients able to walk immediately post-surgery using a specialized postoperative shoe rather than requiring weeks of non-weight bearing with casts or crutches. The miniBunion® 3D procedure corrects bunions in three dimensions, minimizing tissue damage and scarring. Insurance coverage is typically available for these procedures as they are classified as bunion correction surgeries. The company supports surgeons and patients through educational content, surgeon locator services, and patient testimonials demonstrating clinical outcomes and quality of life improvements.

Mid South Precision is an American CNC manufacturing and contract machining specialist with 27 years of medical industry experience. The company manufactures complex surgical devices and medical implants using high-speed CNC lathes, Swiss machines, and up to 5-axis milling equipment on implant-grade materials. Core capabilities include medical and contract machining, mechanical assembly, and medical-grade finishing with strict adherence to tight tolerances and complex geometries. ISO 13485 certified quality management system; FDA registered (Registration #3011189525). Services span both high-volume and low-volume production runs. MSP emphasizes customer collaboration and communication built on deep industry familiarity, positioning itself as a B2B contract manufacturer for medical device OEMs and implant suppliers requiring precision-machined components.

Signature Orthopaedics is an orthopedic medical device manufacturer headquartered in Australia with US operations. The company designs, prototypes, and manufactures orthopedic implants and instruments in-house, including hip stems (Everglade™, Origin™, Origin-NS™, Evolve™, Pegasus™, Aria™, Remedy™), knee systems (World® Knee), acetabular cups (Logical™, World® Acetabular), spinal implants, shoulder soft-tissue fixation devices, and extremity products. Signature Orthopaedics operates integrated design, CAD, prototyping (3D printing, CNC), testing, and production facilities with capabilities for both metals and plastics manufacturing. The company possesses regulatory expertise and post-market surveillance infrastructure. Products appear to be Class III medical devices marketed to orthopedic surgeons and hospitals across multiple regions including Australia, USA, Ireland, UK, and France. Manufacturing and quality processes support sterile, finished-product delivery without external processing.

Demetra Holding is an international, independent healthcare company founded in 2016 (celebrating 10th anniversary in 2026) that aggregates and directly controls specialized medical device manufacturers focused on orthopedic and spinal surgery. The holding company portfolio includes Tecres (acrylic bone cements, vertebroplasty, neuroradiology, neurosurgery applications), Osartis (medical biomaterials developer with 25+ years of history), OsteoRemedies (US-based infection remedies and revision orthopedic solutions), GetSet Surgical (Swiss-based sterile-packaged spine implants and instrument sets), OrthoFundamentals (SI Joint Fusion implants and single-use instrument kits), and Yijiutai (joint venture with KMC for Chinese market). Demetra positions itself as a leader in PJI (prosthetic joint infection) management and spinal surgery. The company operates across multiple regulatory jurisdictions (EU, US, China) and maintains R&D, production, and warehouse facilities. All subsidiary companies focus on orthopedic biomaterials, bone cements, revision and infection-management solutions, and sterile-packaged surgical instrument sets. The holding company functions as an incubator and consolidator of forward-thinking independent orthopedic device manufacturers.

ChoiceSpine LLC is a Knoxville, Tennessee-based medical device manufacturer specializing in spinal implants, instrumentation, and biologics for complex spine disorders and deformities. Founded in 2006 and currently owned by Zavation Medical Products (acquired 2024), the company develops innovative spinal fusion solutions guided by its "Spine the Right Way ℠" philosophy. ChoiceSpine's product portfolio includes proprietary 3D-printed titanium implants with BioBond® porous trabecular structures, cervical fusion systems, anterior and lateral lumbar interbody spacers, minimally invasive pedicle screw systems, sacroiliac joint fixation devices, and vertebral body replacement systems. The company also provides comprehensive osteobiologic solutions including demineralized bone matrix, bioactive synthetic bone grafts, and structural allografts. ChoiceSpine emphasizes surgeon collaboration and clinical efficacy, offering products for standalone and supplemental fixation applications across cervical, thoracolumbar, and sacroiliac spine regions.

3Spine, Inc. is a medical device company specializing in lumbar spine total joint replacement technology. The company develops and commercializes MOTUS®, the first total joint replacement (TJR) system for the lumbar spine, designed to replace the function of intervertebral discs and facet joints while preserving spinal motion and range of motion—contrasting with traditional spinal fusion approaches that eliminate motion. MOTUS is indicated for biomechanical reconstruction and stabilization of a spinal motion segment following decompression at one lumbar level (L1/L2 to L5/S1) in patients with degenerative disc disease, spinal stenosis, facet arthrosis, spinal instability, and associated symptoms. The device employs a posterior surgical approach using a novel pedicle-based osteotomy technique that allows up to 20 degrees of lordotic correction at a single level. 3Spine originated as a Medtronic spin-out; Medtronic developed the foundational three-column intellectual property in 2004 under the KENAI device program. The portfolio was spun to private ownership in 2014, acquired by International Surgical in 2016 (rebranded as BalancedBack and later MOTUS), and is now fully independent and capitalized. The MOTUS device is currently approved for investigational use only in the United States under FDA Investigational Device Exemption (IDE NCT05438719), with enrollment completed in 2023. 3Spine obtained FDA Breakthrough Device Designation in 2020 and plans to pursue Pre-Market Approval (PMA) for commercial distribution as IDE data matures. Clinical pilot studies showed 2.4× improvement in Oswestry Disability Index (ODI) Substantial Clinical Benefit, 3.3× improvement in Minimum Symptom State, and 4.1× improvement in Minimally Important Clinical Benefit versus fusion at 12 months, with sustained improvements at 24 months. The procedure is tracked under CPT code 0719T. The company serves orthopedic surgeons and spine centers in the United States and operates a cadre of clinical, regulatory, and product development expertise.

Fillauer Companies is a Chattanooga, Tennessee–based prosthetics and orthotics manufacturer with over a century of operational history. The company designs and manufactures lower-limb prosthetic feet, upper-limb myoelectric terminal devices (powered hands), and orthotic systems for foot-ankle support. Key product lines include the AllPro series (AllPro XTS, AllPro PM, AllPro DM) for lower-limb prosthetics; the Zeus hand family (Zeus S, Zeus M with quick disconnect and flex wrist options) for upper-limb myoelectric prosthetics; the Formula product line (Formula Pediatric, Formula Fit, Formula Ultra) for variable activity levels; and the TASKA PowerCore system for socket fabrication and prosthetic power delivery. The company serves both professional prosthetics clinicians and end-users (amputees and individuals requiring orthotic support), with a stated focus on K3–K4 functional mobility and active lifestyle restoration. Products are marketed for users ranging from adolescents to adults across diverse activity profiles (athletics, martial arts, cycling, CrossFit). The company maintains a professional-facing business unit supporting prosthetists and clinicians, and a consumer-facing community platform. Manufacturing and distribution appear to be US-based, with regulatory compliance appropriate for medical devices (FDA clearance typical for prosthetic components and myoelectric systems). The organization emphasizes innovative socket design, power reliability, and functional outcomes.

OsteoRemedies, LLC is an FDA-cleared orthopedic medical device manufacturer specializing in complex joint infection management and revision arthroplasty solutions. Founded in 2013 and headquartered in Memphis, Tennessee, the company designs and produces innovative devices for two-stage infection revisions of hip, knee, and shoulder joints. The product portfolio includes the proprietary REMEDY® Spacer System, antibiotic-loaded bone cements, debridement instruments, irrigation solutions, and antimicrobial wound management systems. OsteoRemedies addresses the critical clinical need for effective biofilm management and infection control in orthopedic surgery, offering surgeons comprehensive toolsets to optimize patient outcomes in complex revision procedures. The company maintains AdvaMed Code of Ethics compliance and emphasizes quality assurance and continuous product improvement.

Autocam Medical is a privately held contract manufacturer of precision-machined surgical implants, instruments, and components for orthopedic and spinal procedures. The company specializes in complex, highly engineered products including surgical drill bits, drivers, screws, plates, cutting tools, and other device components used in spine, foot and ankle, hand and wrist, hip and knee, shoulder and elbow, and craniomaxillofacial procedures. Autocam Medical operates as a B2B supplier to OEM partners and device manufacturers rather than direct end-users. Core manufacturing capabilities include CNC milling, turning, and cutter grinding, with state-of-the-art equipment and design-for-manufacturing engineering integrated throughout the production process. The company emphasizes supply chain stability, long-term partnerships, early design collaboration with customers, and disciplined quality systems to protect product launches and reduce supply risk. In 2024, Autocam Medical completed a $60 million expansion with a new 100,000-square-foot facility in Kentwood, Michigan (global headquarters), which houses proprietary manufacturing processes and is expected to create approximately 250 jobs. The company operates with a privately held ownership structure and explicitly positions itself as an alternative to large suppliers with slower response times or smaller shops with capacity constraints. Manufacturing certifications and regulatory compliance standards are not explicitly detailed on the website, though the medical device manufacturing focus suggests FDA compliance requirements.

Vilex LLC is a dedicated lower extremity medical device company specializing in foot and ankle surgical solutions. The company develops and markets a comprehensive portfolio of orthopedic implants and fixation systems for foot and ankle reconstruction, including total ankle replacement systems, external fixation devices, intramedullary nailing systems, locking plate systems, and compression staple systems. Key product lines include the Hintermann Series H2 and H3 total ankle replacement systems (fixed-bearing and mobile-bearing designs, with over 30,000 units implanted globally), Dynex external fixation system, Redemption midfoot nails and beams, Alphalok locking plating systems (Recon, MetFX, AnkleFX variants), Hammerfuze hammertoe compression system, Fibunail fibular intramedullary nail system, Nitinex nitinol compression staples, and MEND/EPF endoscopy systems. The company positions itself as surgeon-driven, emphasizing product development guided by surgeon feedback. Vilex markets to foot and ankle surgeons and orthopedic surgical centers. The company demonstrates significant market presence and clinical validation, particularly with the Hintermann total ankle replacement platform, which has a 20-year clinical history. Products appear to carry regulatory clearances typical of orthopedic implant devices sold in the US market, though specific 510(k) or FDA classifications are not detailed on the homepage. Manufacturing and distribution capabilities support both domestic and international markets.

MicroPort Orthopedics Inc. is an orthopedic medical device manufacturer specializing in joint reconstruction implants and robotic-assisted surgical systems. The company has 50 years of orthopedic implant manufacturing experience and markets products across 70 countries worldwide. Primary product lines include total knee replacement systems, total hip replacement systems, and the SkyWalker® robotic-assisted surgical platform. The Evolution® Medial-Pivot Knee is a flagship product offering validated long-term clinical outcomes (25-year track record) and features proprietary kinematic design. The Evolution® NitrX™ Knee incorporates a titanium niobium nitride (TiNbN) coating designed to reduce metallic ion release common in standard CoCr implants. Hip offerings emphasize tissue-sparing surgical approaches such as SuperPath®, designed to reduce hospital length of stay and improve patient recovery. The SkyWalker® Surgical Robot is FDA-cleared in the U.S. and CE-marked internationally; distributed by MicroPort through partnership with MicroPort NaviBot International LLC. The company reports continuous innovation with 10 new products launched in the last 3 years. Manufacturing and distribution infrastructure supports hospital and surgical center customers globally.